- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Mangalam Drugs has announced a board meeting where the financial results for the quarter were approved. The company reported a consolidated net loss of ₹13.80 Cr on ₹57.35 Cr revenue. A meeting for the ongoing merger with Mangalam Laboratories and Shri JB Pharma is set for August 12.